China National Medicines (SHSE:600511) 3-Year EBITDA Growth Rate : 13.80% (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines 3-Year EBITDA Growth Rate?

China National Medicines's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.82.

During the past 12 months, China National Medicines's average EBITDA Per Share Growth Rate was 8.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China National Medicines was 59.90% per year. The lowest was 1.90% per year. And the median was 20.50% per year.

Competitive Comparison of China National Medicines's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, China National Medicines's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Medicines's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where China National Medicines's 3-Year EBITDA Growth Rate falls into.

China National Medicines 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

China National Medicines (SHSE:600511) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

China National Medicines 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of China National Medicines's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines